Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Dinoprost and Phosphatidic Acid

Research Papers that Mention the Interaction

In day 2 corpora lutea, PGF2 alpha , (10 microM) and GnRHa (100 ng/ml) significantly increased 32PO4 incorporation into phosphatidic acid (PA) and phosphatidylinositol (PI), but not into other fractions.
Endocrinology  •  1988  |  View Paper
In addition, PGF2 alpha increased inositol phospholipid turnover, as evidenced by increased 32PO4 incorporation into phosphatidic acid and phosphatidylinositol.
Proceedings of the National Academy of Sciences of the United States of America  •  1987  |  View Paper
By contrast, the levels of the 32P-prelabeled phosphatidylinositol and phosphatidic acid were increased at 5 min by PGF2 alpha or LHRH.
Endocrinology  •  1986  |  View Paper
Incorporation of radioactivity into PA was already increased (p less than 0.05) by 2 min following PGF2 alpha addition, while the increase in 32P-labeled PI became significant (p less than 0.01) by 5 min.
Canadian journal of physiology and pharmacology  •  1985  |  View Paper
GnRH or PGF2 alpha causes a rapid and marked increase of labelling of phosphatidylinositol (PI) and phosphatidic acid ( PA ) in rat luteal cells in culture.
Canadian journal of physiology and pharmacology  •  1985  |  View Paper